TIMP1, TIMP metallopeptidase inhibitor 1, 7076

N. diseases: 603; N. variants: 4
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0019618
Disease: Histiocytosis
Histiocytosis
0.010 Biomarker disease BEFREE To explore the pathogenesis that TIMP-1 mediated in adult orbital xanthogranulomatous disease (AOXGD), a rare type of non-Langerhans histiocytosis that damages the appearance and quality of life of patients Methods: We reviewed 22 patients diagnosed with AOXGD based on clinical manifestations and histological analysis, and then investigated the expression of TIMP-1 and IL-6 with q-PCR and IHC in AOXGD tissues and the possible mechanism involved in the induction of TIMP-1 by IL-6. 30973282 2020
CUI: C0027796
Disease: Neuralgia
Neuralgia
0.010 GeneticVariation phenotype BEFREE Noteworthy, 13 hub genes associated with neuropathic pain and nerve regeneration, including Ccl12, Ppp1r15a, Cdkn1a, Atf3, Nts, Dusp1, Ccl7, Csf, Gadd45a, Serpine1, Timp1 were rarely reported in PubMed database, these genes may provide us the new orientation in experimental research and clinical study. 29672183 2020
CUI: C0029883
Disease: Otitis Media with Effusion
Otitis Media with Effusion
0.010 Biomarker disease BEFREE The changes in the concentrations of MMP-8, MMP-9 and TIMP-1 may indicate an increased remodeling of the extracellular matrix in children with adenoid hypertrophy and otitis media with effusion. 31606684 2020
CUI: C0039538
Disease: Teratoma
Teratoma
0.010 Biomarker disease BEFREE In this study, neural stem cell-conditioned medium (NSC-CM) and/or TIMP proteins prevented teratoma growth in vivo. 31778275 2020
CUI: C0041318
Disease: Tuberculosis, Meningeal
Tuberculosis, Meningeal
0.010 Biomarker disease BEFREE The concentrations of matrix metalloproteinase 9 (MMP-9), MMP-2, tissue inhibitor of metalloproteinase 1 (TIMP-1), and TIMP-2 were significantly elevated in the lumbar CSF samples, and we found interesting dynamics for MMP-9 that offer novel insight into its role in pediatric patients with tuberculous meningitis. 30753686 2020
CUI: C0149825
Disease: Hypertrophy of adenoids
Hypertrophy of adenoids
0.010 Biomarker disease BEFREE The changes in the concentrations of MMP-8, MMP-9 and TIMP-1 may indicate an increased remodeling of the extracellular matrix in children with adenoid hypertrophy and otitis media with effusion. 31606684 2020
CUI: C0231586
Disease: Joint function disorder
Joint function disorder
0.010 Biomarker disease BEFREE Therefore, we aimed to investigate the effect of controlling abnormal joint movement on gait performance and the localization of MMP13 and TIMP-1, using kinematic and histological analyses. 29938527 2020
CUI: C0271449
Disease: Exudative otitis media
Exudative otitis media
0.010 Biomarker disease BEFREE The aim of the current study was to assess the levels of MMP-8, MMP-9 and TIMP-1 in the group of children with adenoids who suffered from exudative otitis media. 31606684 2020
CUI: C0345905
Disease: Intrahepatic Cholangiocarcinoma
Intrahepatic Cholangiocarcinoma
0.010 Biomarker disease BEFREE Mechanistically, we found that the phosphatidylinositol 3-kinase-AKT signal pathway and its downstream effectors, such as tissue inhibitor of metalloproteinases 1 and matrix metallopeptidase 9, were required for MUC13-mediated tumor metastasis of iCCA. 31837357 2020
CUI: C0393639
Disease: Hashimoto's encephalitis
Hashimoto's encephalitis
0.010 AlteredExpression disease BEFREE In this study, we aimed to evaluate the association of serum matrix metallopeptidase-9 (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) levels with the neurological prognosis of AE. 31843295 2020
CUI: C0398597
Disease: Histiocytic syndrome
Histiocytic syndrome
0.010 Biomarker disease BEFREE To explore the pathogenesis that TIMP-1 mediated in adult orbital xanthogranulomatous disease (AOXGD), a rare type of non-Langerhans histiocytosis that damages the appearance and quality of life of patients Methods: We reviewed 22 patients diagnosed with AOXGD based on clinical manifestations and histological analysis, and then investigated the expression of TIMP-1 and IL-6 with q-PCR and IHC in AOXGD tissues and the possible mechanism involved in the induction of TIMP-1 by IL-6. 30973282 2020
CUI: C1368898
Disease: Adult Teratoma
Adult Teratoma
0.010 Biomarker disease BEFREE In this study, neural stem cell-conditioned medium (NSC-CM) and/or TIMP proteins prevented teratoma growth in vivo. 31778275 2020
CUI: C2347762
Disease: Childhood Teratoma
Childhood Teratoma
0.010 Biomarker disease BEFREE In this study, neural stem cell-conditioned medium (NSC-CM) and/or TIMP proteins prevented teratoma growth in vivo. 31778275 2020
CUI: C2945695
Disease: Limb ischemia
Limb ischemia
0.010 AlteredExpression disease BEFREE Coexistence of proangiogenic potential and increased MMP-9, TIMP-1, and TIMP-2 levels in the plasma of patients with critical limb ischemia. 31273966 2020
Primary cholangiocarcinoma of intrahepatic biliary tract
0.010 Biomarker disease BEFREE Mechanistically, we found that the phosphatidylinositol 3-kinase-AKT signal pathway and its downstream effectors, such as tissue inhibitor of metalloproteinases 1 and matrix metallopeptidase 9, were required for MUC13-mediated tumor metastasis of iCCA. 31837357 2020
CUI: C0002871
Disease: Anemia
Anemia
0.010 Biomarker disease BEFREE Anemia decreased TIMP-1 in rats fed fermented goat milk with Fe overload, whereas there was increased CTGF and MCP-1 in animals fed fermented cow milk with either normal or Fe overload. 30014470 2019
CUI: C0005694
Disease: Bladder neck obstruction
Bladder neck obstruction
0.010 AlteredExpression disease BEFREE The expression of MMP-1 was significantly decreased accompanying with increased TIMP-1 expression in BOO rats compared with that in Sham rats, which was ameliorated by SFN treatment. 31316719 2019
CUI: C0007107
Disease: Malignant neoplasm of larynx
Malignant neoplasm of larynx
0.010 AlteredExpression disease BEFREE The aim of this study was to assess the expression of MMP-9 and TIMP-1 in cancerous tissue as well as in the serum and plasma concentrations of these proteins in patients with laryngeal cancer and compare the results to the inflammatory reaction in healthy subjects. 31143300 2019
CUI: C0007222
Disease: Cardiovascular Diseases
Cardiovascular Diseases
0.010 Biomarker group BEFREE Background Tissue inhibitor of metalloproteinases-1 ( TIMP -1) and procollagen type III aminoterminal peptide are established circulating markers of extracellular matrix remodeling and associated with cardiovascular disease. 30890055 2019
CUI: C0008677
Disease: Bronchitis, Chronic
Bronchitis, Chronic
0.010 Biomarker disease BEFREE Transcript expression of pro-inflammatory (CXCL8, IL6, TNF, NFKB), oxidative stress (HMOX1, SOD3, GSTA1, GPx), tissue injury/repair (MMP9/TIMP1) and bronchial cell type markers (MUC5AC, CC10) were assessed using qRT-PCR.Increased secretion of CXCL-8 and MMP-9 markers was detected 24<b> </b>h post-exposure in both PBEC-ALI and PBEC-ALI/CB with more pronounced effect in the later. 31462114 2019
CUI: C0017574
Disease: Gingivitis
Gingivitis
0.010 Biomarker disease BEFREE Salivary levels of MPO, MMP-8 and TIMP-1 are associated with gingival inflammation response patterns during experimental gingivitis. 30626536 2019
CUI: C0023827
Disease: liposarcoma
liposarcoma
0.010 AlteredExpression disease BEFREE Here we show that tissue inhibitors of metalloproteinases (TIMPs) from TIMP-1 to TIMP-4 are differently expressed and regulate yes-associated protein (YAP)/transcriptional co-activator with PDZ binding motif (TAZ) in LS. 31074490 2019
CUI: C0024143
Disease: Lupus Nephritis
Lupus Nephritis
0.010 Biomarker disease BEFREE We performed immunohistochemistry with monoclonal antibodies against MMP-1, MMP-2, MMP-3, MMP-9, and TIMP-1 in 58 kidney-biopsy specimens with LN (according to the 2004 ISN/RPS classification) and eight specimens from normal kidney tissue. 30973283 2019
CUI: C0028259
Disease: Nodule
Nodule
0.010 Biomarker phenotype BEFREE The effect of TIMP1 on pulp cell functions related to hard tissue formation as part of the wound healing process (i.e. biocompatibility, proliferation, differentiation and mineralized nodule formation) was evaluated in vitro and using a direct pulp capping experimental animal model in vivo. 30761555 2019
CUI: C0031030
Disease: Periapical Periodontitis
Periapical Periodontitis
0.010 AlteredExpression disease BEFREE Expression of WNT3, WNT3A and WNT5A in AP tissues was significantly higher than in control tissues, and inversely correlated with the expression of SERPINB1, COL1A1 and TIMP1 (P < 0.05). 31831777 2019